article Open AccessTop 10% cited
Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitor
Bioorganic & Medicinal Chemistry Letters · 2002 · Vol. 12(8) · pp. 1219–1223
James E. Thompson✉(Merck & Co., Inc., Rahway, NJ, USA (United States))Rose M. Cubbon(Merck & Co., Inc., Rahway, NJ, USA (United States))Richard Cummings(Merck & Co., Inc., Rahway, NJ, USA (United States))Linda S. Wicker(Merck & Co., Inc., Rahway, NJ, USA (United States))Robert A. Frankshun(Merck & Co., Inc., Rahway, NJ, USA (United States))Barry R. Cunningham(Merck & Co., Inc., Rahway, NJ, USA (United States))Patricia M. Cameron(Merck & Co., Inc., Rahway, NJ, USA (United States))Peter T. Meinke(Merck & Co., Inc., Rahway, NJ, USA (United States))Nigel J. Liverton(Merck & Co., Inc., Rahway, NJ, USA (United States))Youmin Weng(Merck & Co., Inc., Rahway, NJ, USA (United States))Julie A. DeMartino(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cytokine Signaling Pathways and InteractionsBioactive Compounds and Antitumor AgentsMelanoma and MAPK PathwaysChemistryPhosphorylationKinaseImidazoleTyrosine kinaseTyrosine kinase 2Protein kinase AMolecular biologyReceptorBiochemistry
MeSH terms
AnimalsCell DivisionDNA-Binding ProteinsEnzyme InhibitorsInterleukin-2Milk ProteinsPhosphorylationPhotochemistryProtein-Tyrosine KinasesPyridonesTrans-ActivatorsInterleukin-4STAT5 Transcription FactorMiceJanus Kinase 3
Citations
268
FWCI
3.60
field-weighted impact
References
26
Percentile
93%
vs. same field & year
Citations per year
Cited by
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Cancer Cell · 2005 · 2,972 citations
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
PLoS Medicine · 2006 · 1,402 citations
References
The Sequence of the Human Genome
Science · 2001 · 13,619 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.